High expression of the chemokine receptor 4, CXCR4, associated to negative prognosis in acute myeloid leukemia, is related to hypoxia. Because CXCR4 expression is under the posttranscriptional control of microRNA-146a in normal and leukemic monocytic cells, we first investigated the impact of hypoxia on microRNA-146a and CXCR4 expression during monocytopoiesis and in acute monocytic leukemia. Then, we analyzed the effects of hypoxia on drug sensitivity of CXCR4-expressing leukemic cells.
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Introduction
In the bone marrow (BM), the most primitive stem cells are maintained in hypoxic niches that regulate the fate of these cells and hematopoietic progenitor cells (HSCs/HPCs) in terms of quiescence, self-renewal and differentiation. [1] [2] [3] [4] [5] [6] Leukemic cells can infiltrate the niches leading to their enhanced self-renewal and proliferation, quiescence and resistance to chemotherapeutic agents. 7, 8 Then, hypoxia is associated with poor prognosis in leukemia, especially in acute myeloid leukemia (AML), [9] [10] [11] [12] [13] as also described in cancer and inflammatory diseases. 8, 14 Adaptation of leukemic cells to the BM microenvironment is important in the clonal selection that leads to leukemia progression, drug resistance and relapse. [7] [8] [9] [10] [11] 14 To survive in hypoxia, cells activate adaptive responses, including gene regulation by hypoxia-inducible factors (HIFs)-1alpha
(HIF-1α) and -2alpha (HIF-2α). 15, 16 Hypoxia allows HIFs to escape from normoxia-mediated degradation in the cytoplasm and to translocate into nuclei where they bind to hypoxia-response elements (HREs) within the regulatory regions of target genes [17] [18] [19] [20] and microRNAs. 21, 22 Also, the use of inhibitors of HIFs represents a new strategy for the development of therapies targeting the hypoxic cancer microenvironment. [23] [24] [25] [26] [27] Stabilization of HIFs proteins by dimethyloxalyl glycine treatment, increases HSC quiescence in vivo, improves blood recovery and enhances HSC survival in the BM of irradiated mice. 23 Echinomycin, a DNA-intercalator agent that blocks HIFs DNA-binding activity, selectively eradicates cancer stem cells in mouse models of lymphoma and human AML 24 and selectively kills the leukemia-initiating cell inducing long-term remission in a murine model of relapsed AML.
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The chemokine receptor CXCR4 and its ligand stromal-derived factor-1alpha (SDF-1/CXCL12) are both major players in the cross-talk between leukemic cells and the BM microenvironment. [10] [11] [12] In AML patients, hypoxia-induced CXCR4 expression is associated with poor prognosis, independently of the presence or not of the mutated FLT3 gene. 12, 28 CXCR4 is a target gene of microRNA-146a (miR-146a) 29 , among several other microRNAs targeting this gene. [30] [31] [32] miR-146a is a modulator of the innate and adaptive immunity, involved in
We previously identified the molecular mechanism that regulates CXCR4 protein expression level by miR-146a targeting 29 (miR-146a/CXCR4) during monocytopoiesis. 39 We also reported that in acute monocytic leukemia AML-M5, high CXCR4 protein level is associated with low/absent miR146a expression. 39 Then, we showed that miR-146a enforced expression in leukemic cells decreases CXCR4 protein level and improves the drug sensitivity of these cells.
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CXCR4 is a target gene of HIF-1α and a posttranscriptional target of miR-146a, 9 ,39 in monocytic (Mo) cells, known to originate from a common myeloid precursor in the BM giving rise to tissue macrophages and dendritic cells 40 and subject to very different oxygen (O 2 ) levels. 41 In this study, we investigated the impact of a chronic hypoxia, from mild (5% O 2 ) as observed in BM at the level of the sinusoidal cavity, to more severe (1% O 2 ) as observed in BM at the level of hypoxic niches, on the miR-146a/CXCR4 regulatory axis during monocytopoiesis and in Mo leukemic cells.
Altogether, our data demonstrated how the differential expression of HIF-1α and HIF-2α is mediated by O 2 level, either mild or severe, and downregulates CXCR4 expression through a posttranscriptional mechanism mediated by upregulation of miR-146a in normal monocytic cells and in monocytic leukemia cell lines, expressing a moderate level of CXCR4. However, this mechanism is dysregulated in primary AML-M5 blast cells that fail to significantly decrease CXCR4 expression in response to hypoxia. This dysregulation helps to understand how leukemic blasts express high CXCR4 levels, even in hypoxic conditions, and how they are protected from anti-leukemic drugs through CXCR4 activation mediated by SDF-1α secreted in the hypoxic BM microenvironment.
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Methods
Additional information is provided in the Online Supplement.
Cell cultures
Human cord blood (CB) were obtained from healthy donors after informed consent. AML patient blood samples were collected, after informed consent. This study was approved by local ethical committees of Istituto Superiore di Sanità and University of Tor Vergata.
CB CD34 + HPC purification, unilineage monocytic differentiation and morphologic analysis were performed as previously described.
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Human primary AML-M5 blasts were maintained in culture in vitro in Iscove's medium supplemented with 10% FCS, GM-CSF (10 ng/ml), SCF (50 ng/ml), IL-3 (10 ng/ml) (PeproTech Inc. Rocky Hill, NJ, USA). RNA and protein samples were prepared as described.
Leukemic cell lines, U937 and HL-60, were grown in RPMI medium supplemented with 10% FCS (Gibco, Carlsbad, CA, USA).
Hypoxia
To provide a chronic (from 20 hours to several days) or acute (1 to 6 hours), mild (5% O 2 ) or severe (1% O 2 ) hypoxic environment, cells were cultured and treated in sealed incubators calibrated for a constant hypoxic environment, 5% O 2 , 90% N 2 and 5% CO 2 referred as mild hypoxia, or to 1% O 2 , 94% N 2 and 5% CO 2 referred as severe hypoxia, at temperature 37°C. For physiological oxygenation or normoxia (N), cells were cultured in an incubator calibrated to 21% O 2 .
Gene Silencing of HIFs by Small interfering RNA (siRNA)
U937 cells were transfected twice over with 100 nM of short interfering ribonucleic acids HIF-1α-or HIF-2α-siRNA (ON-TARGET plus SMART pool siR J004018-10 for HIF-1α and J004814-09
for HIF-2α, from Dharmacon, CO, USA), or non-targeting control siRNA (c-siRNA) (ON-TARGET plus Non-Targeting Pool D-001810-10-05, from Dharmacon) by using Lipofectamine 3000 as described. 29 Transfected U937(HIF-1α-siRNA), U937(HIF-2α-siRNA) and U937(c-siRNA) 
Results
Severe hypoxia delays Mo proliferation and differentiation of HPCs, activates microRNA-146a and downmodulates CXCR4 protein expression
We investigated the effect of severe hypoxia (1% O 2 ) on the proliferation and differentiation of monocytic cells derived from human CD34 + cells, as compared with mild (5% O 2 ) hypoxia.
Severe hypoxia impairs cell growth ( Figure 1A Figure S1C) . Importantly, the percentage of apoptotic cells was similar at all days of culture for cells grown under mild and severe hypoxia (data not shown).
We analyzed the expression and regulation of miR-146a and CXCR4 in our Mo cultures. Under mild hypoxia, miR-146a and CXCR4mRNA expression levels decrease during the first days (d0-d5) of monocytopoiesis ( Figure 1D -E), thus unblocking the translation of CXCR4mRNA that results in increased CXCR4 protein level ( Figure 1F ). Later during Mo maturation (d5-d20),
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CXCR4 protein level decreases ( Figure 1F ) while CXCR4mRNA level remains constant ( Figure   1E ) and miR-146a increases ( Figure 1D ).
Severe hypoxia has a major effect in upregulating miR-146a and CXCR4 mRNA expression levels, as compared to mild hypoxia ( Figure 1D -E), indicating a hypoxia level-dependent transcriptional activation of these genes in Mo differentiating HPCs. Then, the decrease of CXCR4 protein levels observed under severe hypoxia ( Figure 1F ) is associated with a marked increase of miR-146a
( Figure 1D ) that blocks CXCR4 mRNA translation, according to the previously described mechanism of post-transcriptional control of CXCR4 expression by miR-146a targeting.
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Altogether, we showed that severe hypoxia impairs Mo differentiation of HPCs and activates the miR-146a/CXCR4 regulation to control CXCR4 level.
The differential expression of HIF-1α and HIF-2α depends on the level of hypoxia during Mo proliferation and differentiation of HPCs
To investigate the molecular mechanisms involved in the hypoxia-mediated control of monocytopoiesis, we analyzed HIFs expression in Mo differentiating HPCs grown under mild and severe hypoxic conditions.
Under mild hypoxia, HIF-1α expression at mRNA and nuclear protein level is high in quiescent Altogether, we reported that the differential expression of HIF-1α and HIF-2α observed throughout monocytopoiesis is hypoxia level-dependent, and severe hypoxia is required to activate HIF-1α in Mo cells.
In Mo differentiating HPCs, microRNA-146a is a new shared target of HIF-1α and HIF-2α
We investigated whether miR-146a is a direct target of HIF-1α or HIF-2α in Mo cells. We found a HRE related sequence 5'-GACTGGAGTGCAGTGGTGCAATCATAGC-3' at position (-393; -422) in the promoter region of miR-146a 29 (Prom-miR146a) ( Figure 2A ) that we identified as a new HIF-DNA binding site of both HIF-1α and HIF-2α, in vitro. Luciferase assays were performed using the reporter pGL3Basic-Prom146a vector previously described, 29 in presence or not of HIF-1α or HIF-2α expression vectors ( Figure 2B ). Our data showed that both HIF-1α and HIF-2α expression caused a 40% activation of the Prom-miR146a, but not of the reporter pGL3Basic-MutProm146a vector containing a mutant version of the HRE in the Prom-miR146a (Mut-Prom146a) ( Figure 2B ). Overall, the newly identified HRE in the promoter of miR-146a is able to bind in vitro HIF-1α and HIF-2α, both acting as transcriptional activators of miR-146a.
We verified the recruitment of protein HIF-1α or HIF-2α to HRE sites identified into CXCR4 and miR-146a promoters 29, 44 with ChIP experiments performed by using nuclear extracts derived from Mo cells grown under mild and severe hypoxia ( Figure 2C-D) .
We found that under mild hypoxia, at day 12 Mo cells, Prom-miR-146a is a specific target of HIF-2α, but not of HIF-1α ( Figure 2C : Prom-miR146a); in contrast, Prom-CXCR4 is an unique target of HIF-1α in the same Mo cells, even if HIF-1α specific binding to Prom-CXCR4 is very weak ( Figure   2C : Prom-CXCR4), as expected according to the low level of HIF-1α protein present in Mo cells at this time.
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After two weeks of Mo culture under severe hypoxia, ChIP experiments indicate that miR-146a is an unique target of HIF-1α ( Figure 2D : Prom-miR146a). In line with this finding, whereas HIF-1α
and HIF-2α mRNAs are both expressed in Mo cells (d15-d20, Figure 1G , 1I), HIF-1α nuclear protein level is high, as compared to HIF-2α ( Figure 1H ). HIF-1α specific binding to Prom-CXCR4
was also detectable at day 18 Mo cells ( Figure 2D : Prom-CXCR4), in line with CXCR4mRNA level found in these cells ( Figure 1E ).
Our data showed that chronic mild and severe hypoxia upregulate miR-146a and CXCR4mRNA expression by HIF-1α or HIF-2α differential targeting and HIF-1α targeting, respectively, during
Mo differentiation.
In monocytic leukemic cells, mild hypoxia is sufficient to activate HIF-1α-mediated control of microRNA-146a and CXCR4mRNA
To investigate the impact of hypoxia on the miR-146a/CXCR4 regulation, we analyzed the effects of mild or severe hypoxia on U937 cells used as a model of Mo leukemic cells.
Severe hypoxia induces a decrease of U937 cell growth, compared with mild hypoxia or normoxia ( Figure 3A , day 0-3); apoptosis is observed only at late times in these culture ( Figure 3B , day 4), thus indicating the capacity of U937 cells to survive under severe hypoxia for few days.
We found that mild and severe hypoxia induce both HIF-1α and HIF-2α nuclear proteins accumulation in leukemic cells ( Figure 3C-F) . It is important to note the biphasic modulation of CXCR4 by hypoxia in leukemic cells. After 1 hour of mild or severe hypoxia, we observed an upregulation of both CXCR4mRNA and protein levels in U937 cells, related to a transcriptional control of CXCR4 (1 hour, Figure 3G -H). However, after 24 hours of hypoxia, we first observed the activation of miR-146a (24-48 hours, Figure 3I ) and then the downmodulation of CXCR4 protein level, indicating a posttranscriptional control of CXCR4mRNA at these times (48-72 hours, Figure   3H ).
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To verify whether HIF-1α or HIF-2α was recruited to the HREs in Prom-miR146a and Prom-CXCR4, 44 we performed ChIP experiments by using nuclear extracts from U937 cells cultured in conditions of mild and severe hypoxia, as compared to normoxia. ChIP assays indicated that HIF-1α is the factor associated to both HREs, the one in Prom-miR146a and the other in Prom-CXCR4, in U937 cells in either mild ( Figure 3J : Hx) or severe hypoxia (data not shown).
Then, to demonstrate that hypoxic-induced changes in CXCR4 protein level are regulated by miR146a, we silenced miR-146a endogenous expression, by transfecting antagomiR-146a or control antagomiR (C) oligonucleotides in hypoxic U937 cells, respectively U937(α-miR-146a) and U937(C) cells, as compared to normoxic cells, (Online Supplementary Figure S2 ). We found that severe hypoxia similarly upregulates HIF-1α nuclear protein expression in both U937(C) and U937(α-miR-146a) cells, as compared to normoxia (Online Supplementary Figure S2A ), thus indicating that miR-146a silencing did not affect the capacity of hypoxia to induce HIF-1α stabilization. CXCR4 total protein level increases in U937(α-miR-146a) cells in both normoxic and hypoxic conditions, as compared to control U937(C) cells (Online Supplementary Figure S2B ). It is important to note that CXCR4 levels observed in hypoxic U937(α-miR-146a) cells are highly comparable to those observed in normoxic U937(C) control cells (Online Supplementary Figure   S2A ). Importantly, miR-146a silencing reduced the inhibitory effect of hypoxia on CXCR4 expression (Online Supplementary Figure S2A ).
Altogether, our data showed that in U937 cells under hypoxia, mild or severe, the transcriptional control of miR-146a and CXCR4mRNA expression is regulated by HIF-1α.
DMOG stabilization of HIFs and HIFs silencing demonstrate that HIF-1α activates microRNA146a and CXCR4mRNA in U937 cells
We used a prolyl hydroxylase inhibitor such as dimethyloxalyl Glycine (DMOG) 42,43 to pharmacologically stabilize HIFs-α proteins in leukemic cells under normoxia and analyzed the effects on miR-146a and CXCR4 expression levels. 
Echinomycin inhibits HIF-1α-mediated activation of microRNA-146a and CXCR4mRNA expression in Mo leukemic cells
To inhibit the hypoxic-mediated activation of miR-146a and CXCR4mRNA expression in U937 cells, we used echinomycin (EC) to treat U937 cells grown under severe hypoxia, as compared to normoxia.
We showed that EC treatment inhibits U937 cell growth rate in a significant way by using 2, 5 and 10 nM EC for 20 hours in both severe hypoxia and normoxia, as compared to untreated cells ( Figure 5A ). For the other experiments we used 2 nM EC since, at this concentration, we didn't detect any significant apoptosis either in hypoxia or in normoxia ( Figure 5B ). We also reported an increased accumulation in S phase of U937 cells treated with 2 nM EC, while cells treated with higher EC concentrations (5-10 nM) displayed an increased accumulation in G2 ( Figure 5C ).
Altogether, we showed that EC treatment (2 and 5 nM) of U937 cells grown under severe hypoxia inhibits CXCR4 mRNA and miR-146a upregulation ( Figure 5D -F), thus confirming the role of HIF-1α as a transcriptional activator of both targets miR-146a and CXCR4mRNA.
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The control of CXCR4 expression mediated by HIF-1α/microRNA-146a axis is deregulated in AML-
M5
We analyzed the impact of chronic mild hypoxia on primary leukemic blast cells from AML-M5.
We reported that AML-M5 frequently express high levels of CXCR4 protein, associated with very low level of miR-146a. 39 Then, we cultured leukemic blast cells from 8 AML-M5 under mild hypoxia for 20 hours, as compared to normoxia, and analyzed HIFs-α nuclear proteins, miR-146a
and CXCR4 expression in these cells.
As observed in U937 cells, we found that mild hypoxia (Hx) is sufficient to induce both HIF-1α and HIF-2α nuclear proteins accumulation in leukemic blast cells, as compared to normoxia (N) ( Figure   6A ). Although the increased HIF-1α nuclear protein level was associated with an increased miR146a level ( Figure 6B ), we didn't observe in AML-M5 the significant decrease of CXCR4 protein level ( Figure 6C ) that we found in U937 cells in hypoxia.
These observations indicate that in AML-M5 the moderate miR-146a upmodulation elicited by hypoxia is not sufficient to induce a significant decrease of CXCR4 protein levels.
In order to understand whether CXCR4 can be downmodulated by higher level of miR-146a expression in AML-M5 leukemic blasts, we transfected these cells with miR-146a mimics. A representative experiment reported in Online Supplementary Figure S3 showed that enforced miR146a overexpression in AML-M5 cells induces a moderate CXCR4 downmodulation.
Hypoxia increases SDF-1α-induced leukemic cells survival by decreasing the sensitivity of leukemic cells to antileukemic drugs
To determine whether hypoxia and CXCR4 activation by SDF-1α protect leukemic cells from apoptosis induced by anti-leukemic drug treatment, we exposed U937 cells, HL-60(CXCR4) and K562(CXCR4) cells engineered to overexpress CXCR4, and AML-M5 cells to cytosine arabinoside, Ara-C (1µM), in combination or not with SDF-1α, and measured cell viability under normoxic and hypoxic conditions of culture ( Figure 7 and Online Supplementary Figure S4 ). In
K562(CXCR4) cells additional experiments have been performed also by incubating these cells with Imatinib, 38 an inhibitor of BCR-ABL, in combination or not with SDF-1α.
We found that hypoxia increases SDF-1α-induced leukemic cell survival of Ara-C-treated U937 cells ( Figure 7A ). In HL-60(CXCR4) cells ( Figure 7B ) we observed similar results ( Figure 7C ), as well as in K562(CXCR4) cells (Online Supplementary Figure S4) . Indeed, we observed again these effects by treating primary leukemic blast cells obtained from two AML-M5 (13 and 14) incubated
with Ara-C alone or in combination with SDF-1α in hypoxia, as compared to normoxia. We observed in both cases an increase of cell survival to Ara-C treatment when Ara-C-treated-blast cells were treated together with SDF-1α, and this effect increased under hypoxia, compared to normoxia ( Figure 7E , F).
As CXCR4 is critically involved in the cross-talk between leukemic cells and bone marrow stromal cells, we also investigated response to chemotherapy of HL-60(CXCR4) cells grown on a MS5 stromal cells (MS5) layer, as compared to standard culture. Cells grown on a MS5 layer exhibited a markedly lower sensitivity to Ara-C under both normoxic and hypoxic conditions ( Figure 7D ).
Altogether, we showed that severe hypoxia cooperates with CXCR4 activation by SDF-1α to induce leukemic cells survival by decreasing the sensitivity of CXCR4-expressing leukemic cells to chemotherapy-induced apoptosis.
Discussion
Like normal hematopoietic stem cells, leukemic cells proliferate in BM where O 2 supply is limited.
Then leukemic cells survive by adapting their metabolism to hypoxic conditions. 45 Adaptation to hypoxia is primarily mediated by two closely related hypoxia-inducible transcription factors HIF-1α and HIF-2α broadly expressed in many human cancers and frequently correlated with poor patient prognosis. HIF-1α and HIF-2α exhibit shared or unique activities in processes that affect tumor growth and metastasis related to their targets genes, such as CXCR4 and its ligand SDF-1/CXCL12, 9-11 but also microRNAs. CXCR4 is involved in homing and mobilization of normal and leukemic cells and its high hypoxiarelated expression is associated to negative prognosis in AMLs. 11,12 Also, the impact of hypoxia on CXCR4 expression and function is currently under investigation in AML.
In this study, we first demonstrated that a variation of chronic hypoxia from 5% O 2 , seemingly representing a physiological mild hypoxic condition for differentiation, to 1% O 2 , a more severe hypoxia observed in BM at the level of hypoxic niches, is a critical variable for HIFs activation during monocytic differentiation/maturation. These data shed light on how the preference between HIF-1α or HIF-2α binding to the promoter of miR-146a depends on the step of Mo differentiation and on the level of hypoxia.
In leukemic monocytic U937 cells first, then in some primary AML-M5, we found that a chronic mild hypoxia upregulates both HIF-1α and HIF-2α concomitantly with miR-146a upmodulation.
Interestingly in leukemic cell lines, severe hypoxia has the same effects of mild hypoxia and HIF-1α is the only one hypoxic-associated factor that induces both miR-146a and CXCR4mRNA upregulation, as demonstrated by DMOG stabilization of HIFs and specific HIF-1α silencing. In this context, it is important to consider the role of some microRNAs like miR-146a, regulated by hypoxia and playing a key role in the modulation of the expression of genes essential for HSC and LSC homing/migration, growth and survival such as CXCR4, to develop new therapeutic strategies that aim to manipulate these microRNAs in leukemia.
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Supplementary Materials and Methods
Cell growth, apoptosis and cell cycle analysis
Cell proliferation, viability of the cells, apoptosis and cell cycle analysis were evaluated by standard procedures (Annexin V-FITC apoptosis kit, 7-aminoactinomycin D and Cycletest Plus DNA detection kits, BD Pharmingen, San Jose, CA, USA).
Flow cytometry (FC) analysis
Analysis of total and membrane CXCR4 protein and Mo membrane markers CD11b and CD14
expression by FC was performed as previously described.
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Western blot analysis
Western blot analysis were performed by using anti-HIF1α-and anti-HIF2α-polyclonal antibodies qRT-PCR specific for miR-146a was performed and normalized using TaqManH MiRNA Assays and protocol (miR-146a assay ID 000468 and RNU6B primer kit ID 001093, Applied Biosystems, Foster City, CA, USA) as previously described.
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Promoter assays
The miR-146a promoter region (Prom-146a) was previously identified and pGL3Basic/Prom-146a vector and activity were characterized. were Southern blotted and hybridized with an internal 32P-labeled oligonucleotide miR-146a* probe 5'-GACTGGAGTGCAGTGGTGCAATCATAGC-3'. As control, a flanking 140 bp genomic region of the Prom-miR146a region, without any HRE site, was amplified by PCR and analyzed using primers, internal probe and PCR conditions as described. 29 Non relevant cellular DNA sequences were detected by amplification of a GAPDH coding region using primers and PCR conditions as described.
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Analysis of HIF-α binding to the HRE previously found in the promoter of CXCR4 (Prom-CXCR4)
was performed using the primers flanking the HRE site, as described, 44 in the same protein-DNA complexes prepared for U937 and Mo cells.
Given the limited number of cells obtained in our cultures, we used Mo cells harvested at day 12 from cultures grown under mild hypoxia, but at day 18 from cultures grown under severe hypoxia, taking into account the delay of cell differentiation observed at 1% O 2 .
Transfection of miR-146a or antagomiR-146a.
miR-146a mimics or antagomiR-146a oligonucleotides, non-targeting RNA or antagomiR oligonucleotides of control and FITC-conjugated non-targeting oligonucleotide (Dharmacon, Lafayette, CO, USA) were used to transfect cells using Lipofectamine 3000 and as described.
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Enforced expression of CXCR4 in HL-60 and K562 cells
By using the previously prepared full-length CXCR4 coding sequence and its 3´UTR region 
Statistical Analysis
Statistical significance of differences observed between different experimental groups was determined using a Student's t test. The minimal level of significance was a P value below 0.05.
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